title: Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
abstract: Two G protein-coupled neurotensin (NT) receptors, termed NTR1 and NTR2, have been identified so far. In contrast to the NTR1, which has been extensively studied, little is known about the pharmacological and biological properties of the NTR2. In the course of characterizing NT analogs that exhibited binding selectivity for the NTR2, we discovered that this receptor constitutively activated inositol phosphate (IP) production. Here, we report on the constitutive activity of the human NTR2 (hNTR2) transfected in COS cells and on compounds that exhibit agonism, inverse agonism, and neutral antagonism at this receptor. IP levels increased linearly with time, whereas they remained constant in mock-transfected cells. Furthermore, IP production was proportional to the amount of hNTR2 present at the cell membrane. SR 48692, a nonpeptide antagonist of the NTR1, stimulated IP production, whereas levocabastine, a nonpeptide histamine H1 antagonist that binds the NTR2 but not the NTR1, behaved as a weak partial inverse agonist. NT analogs modified at position 11 of the NT molecule, in particular by the introduction of bulky aromatic D amino acids, exhibited binding selectivity at the hNTR2 and also behaved as partial inverse agonists, reversing constitutive IP production up to 50%. Finally, NT barely affected constitutive IP production but antagonized the effects of both agonist and inverse agonist compounds, thus behaving as a neutral antagonist. The unique pharmacological profile of the hNTR2 is discussed in the light of its sequence similarity with the NTR1 and the known binding site topology of NT and SR 48692 in the NTR1.
authors.affiliation: Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique (CNRS) Unité Mixte Recherche 6097 Valbonne, France.
authors.forename: F
authors.initials: F
authors.lastname: Richard
authors.forename: S
authors.initials: S
authors.lastname: Barroso
authors.forename: J
authors.initials: J
authors.lastname: Martinez
authors.forename: C
authors.initials: C
authors.lastname: Labbé-Jullié
authors.forename: P
authors.initials: P
authors.lastname: Kitabgi
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D009496:Neurotensin / Q000031:analogs & derivatives / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D018028:Receptors, Neurotensin / Q000819:agonists / Q000037:antagonists & inhibitors*; D017386:Sequence Homology, Amino Acid; D014162:Transfection
chemical_list: D006634:Histamine H1 Antagonists; C490985:NTSR2 protein, human; D010880:Piperidines; D011720:Pyrazoles; D011804:Quinolines; D018028:Receptors, Neurotensin; C079087:SR 48692; D009496:Neurotensin; C047340:levocabastine